{"count": 2, "results": [{"_id": "39365598", "pmid": 39365598, "title": "Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review.", "journal": "Clin Exp Dermatol", "authors": ["Shi M", "Wargon O", "Tatian A"], "date": "2024-10-04T00:00:00Z", "doi": "10.1093/ced/llae401", "meta_date_publication": "2024 Oct 4", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50253.965, "text_hl": "A total of seven studies comparing the two beta-blockers were identified in our search. @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ appeared to be as efficacious as @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ and was associated with fewer @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@central nervous system and bronchial@@@-related @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@adverse@@@ events. ", "citations": {"NLM": "Shi M, Wargon O, Tatian A. Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review. Clin Exp Dermatol. 2024 Oct 4;():. PMID: 39365598", "BibTeX": "@article{39365598, title={Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review.}, author={Shi M and Wargon O and Tatian A}, journal={Clin Exp Dermatol}}"}}, {"_id": "7929868", "pmid": 7929868, "title": "Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.", "journal": "J Clin Pharmacol", "authors": ["Walle PO", "Westergren G", "Dimenäs E", "Olofsson B", "Albrektsen T"], "date": "1994-07-01T00:00:00Z", "doi": "10.1002/j.1552-4604.1994.tb02034.x", "meta_date_publication": "1994 Jul", "meta_volume": "34", "meta_issue": "7", "meta_pages": "742-7", "score": 50050.805, "text_hl": "...@<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@Central nervous system (CNS)-related symptoms@@@ and quality of life during treatment with controlled-release (CR) @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ and a standard formulation of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ were compared in a double-blind crossover study in 60 @SPECIES_9606 @@@patients@@@ with mild to moderate @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Walle PO, Westergren G, Dimenäs E, Olofsson B, Albrektsen T. Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being. J Clin Pharmacol. 1994 Jul;34(7):742-7. PMID: 7929868", "BibTeX": "@article{7929868, title={Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.}, author={Walle PO and Westergren G and Dimenäs E and Olofsson B and Albrektsen T}, journal={J Clin Pharmacol}, volume={34}, number={7}, pages={742-7}}"}}]}